docetaxel- docetaxel anhydrous injection, solution
mylan institutional llc - docetaxel anhydrous (unii: 699121phca) (docetaxel anhydrous - unii:699121phca) - docetaxel injection is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. docetaxel injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer. docetaxel injection as a single agent is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. docetaxel injection in combination with cisplatin is indicated for the treatment of patients with unresectable, locally advanced or metastatic non-small cell lung cancer who have not previously received chemotherapy for this condition. docetaxel injection in combination with prednisone is indicated for the treatment of patients with metastatic castration-resistant prostate cancer. docetaxel injection in combination with cisplatin and fluorouracil is indicated for the treatment of patients with advanced ga
docetaxel anhydrous injection, solution
cipla usa inc. - docetaxel anhydrous (unii: 699121phca) (docetaxel anhydrous - unii:699121phca) - docetaxel injection is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. docetaxel injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer. docetaxel injection as a single agent is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. docetaxel injection in combination with cisplatin is indicated for the treatment of patients with unresectable, locally advanced or metastatic non-small cell lung cancer who have not previously received chemotherapy for this condition. docetaxel injection in combination with prednisone is indicated for the treatment of patients with metastatic castration-resistant metastatic prostate cancer. docetaxel injection in combination with cisplatin and fluorouracil is indicated for the treatment of patients with
docetaxel 20mg/ml concentrate for solution for infusion
seacross pharma (europe) limited - docetaxel anhydrous - concentrate for solution for infusion - 20 milligram(s)/millilitre - taxanes; docetaxel
docetaxel ab 20 mg/ml inf. sol. (conc.) i.v. vial
aurobindo sa-nv - docetaxel 20 mg/0,95 g - concentrate for solution for infusion - 20 mg/ml - docetaxel - docetaxel
docetaxel ab 20 mg/ml inf. sol. (conc.) i.v. vial
aurobindo sa-nv - docetaxel 20 mg/0,95 g - concentrate for solution for infusion - 20 mg/ml - docetaxel - docetaxel
docetaxel ab 20 mg/ml inf. sol. (conc.) i.v. vial
aurobindo sa-nv - docetaxel 20 mg/0,95 g - concentrate for solution for infusion - 20 mg/ml - docetaxel - docetaxel
docetaxel ab 20 mg/ml inf. sol. (conc.) i.v. vial
aurobindo sa-nv - docetaxel 20 mg/0,95 g - concentrate for solution for infusion - 20 mg/ml - docetaxel 20 mg/ml - docetaxel
docetaxel accord 20 mg concentrate and solvent for solution for infusion
accord healthcare - docetaxel anhydrous - concentrate and solvent for solution for infusion - 20 mg - docetaxel anhydrous - docetaxel
docetaxel accord 80 mg concentrate and solvent for solution for infusion
accord healthcare - docetaxel anhydrous - concentrate and solvent for solution for infusion - 80 mg - docetaxel anhydrous - docetaxel
docetaxel eg 20 mg/ml inf. sol. (conc.) i.v. vial
eg sa-nv - docetaxel 20 mg/0,95 g - concentrate for solution for infusion - 20 mg/ml - docetaxel - docetaxel